Albireo Pharma (ALBO) Short Interest Ratio & Short Volume → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free ALBO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Albireo Pharma Short Interest DataCurrent Short Volume553,900 sharesPrevious Short Volume690,300 sharesChange Vs. Previous Month-19.76%Dollar Volume Sold Short$24.47 millionShort Interest Ratio / Days to Cover1.2Last Record DateFebruary 15, 2023Outstanding Shares20,700,000 sharesPercentage of Shares Shorted2.68%Today's Trading Volume1,241,200 sharesAverage Trading Volume704,539 sharesToday's Volume Vs. Average176% Short Selling Albireo Pharma ? Sign up to receive the latest short interest report for Albireo Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALBO Short Interest Over TimeALBO Days to Cover Over TimeALBO Percentage of Float Shorted Over Time Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Albireo Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/2023553,900 shares $24.47 million -19.8%N/A1.2 $44.18 1/31/2023690,300 shares $30.83 million -16.2%3.6%1.9 $44.66 1/15/2023823,300 shares $36.14 million -16.8%N/A2.5 $43.90 12/30/2022988,900 shares $21.37 million -7.6%N/A3 $21.61 12/15/20221,070,000 shares $22.20 million +1.9%N/A4.4 $20.75 11/30/20221,050,000 shares $23.18 million -2.8%N/A3.1 $22.08 Get the Latest News and Ratings for ALBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Albireo Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/15/20221,080,000 shares $24.08 million -35.3%N/A2.9 $22.30 10/31/20221,670,000 shares $34.27 million -5.1%9.1%3.8 $20.52 10/15/20221,760,000 shares $37.98 million -3.3%9.6%4 $21.58 9/30/20221,820,000 shares $35.24 million -13.3%10.0%4.3 $19.36 9/15/20222,100,000 shares $38.39 million +4.5%11.5%5.4 $18.28 8/31/20222,010,000 shares $35.18 million +2.0%11.0%6.2 $17.50 8/15/20221,970,000 shares $49.11 million +0.5%10.8%6.4 $24.93 7/31/20221,960,000 shares $40.75 million +3.7%10.9%6.7 $20.79 7/15/20221,890,000 shares $45.96 million +8.6%10.5%6.5 $24.32 6/30/20221,740,000 shares $34.56 million +13.7%9.4%5.8 $19.86 6/15/20221,530,000 shares $28.53 million +35.4%17.1%5.3 $18.65 5/31/20221,130,000 shares $22.52 million No Change6.1%3.7 $19.93 5/15/20221,130,000 shares $31.64 million +18.6%6.1%3.5 $28.00 4/30/2022952,500 shares $30.31 million -4.8%5.0%3.5 $31.82 4/15/20221,000,000 shares $36.55 million -5.7%5.3%3.6 $36.55 3/31/20221,060,000 shares $31.62 million -20.3%5.6%3.8 $29.83 3/15/20221,330,000 shares $39.46 million +9.9%7.0%4.8 $29.67 2/28/20221,210,000 shares $40.34 million -17.7%6.4%5 $33.34 2/15/20221,470,000 shares $48.61 million +12.2%7.8%6.7 $33.07 1/31/20221,310,000 shares $37.32 million +4.0%7.0%6.3 $28.49 1/15/20221,260,000 shares $34.20 million +7.7%6.7%7 $27.14 12/31/20211,170,000 shares $27.25 million +1.7%6.2%6.8 $23.29 12/15/20211,150,000 shares $25.19 million +1.8%6.1%7.3 $21.90 11/30/20211,130,000 shares $27.11 million +0.9%5.9%7.7 $23.99 11/15/20211,120,000 shares $31.08 million -6.7%5.9%7.4 $27.75 10/29/20211,200,000 shares $35.06 million +3.5%6.3%8.2 $29.22 10/15/20211,160,000 shares $36.24 million -8.7%6.1%7.4 $31.24 9/30/20211,270,000 shares $39.62 million +3.3%6.7%5.6 $31.20 9/15/20211,230,000 shares $35.95 million -26.4%6.5%5.3 $29.23 8/31/20211,670,000 shares $51.02 million -4.0%8.8%7 $30.55 8/13/20211,740,000 shares $50.81 million -3.3%9.2%7.4 $29.20 7/30/20211,800,000 shares $51.50 million +11.8%9.5%7.6 $28.61 7/15/20211,610,000 shares $54.42 million +0.6%8.5%6.9 $33.80 6/30/20211,600,000 shares $56.29 million -13.0%8.5%9 $35.18“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. ALBO Short Interest - Frequently Asked Questions What is Albireo Pharma's current short interest? Short interest is the volume of Albireo Pharma shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 553,900 shares of ALBO short. Learn More on Albireo Pharma's current short interest. What is a good short interest ratio for Albireo Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALBO shares currently have a short interest ratio of 1.0. Learn More on Albireo Pharma's short interest ratio. Is Albireo Pharma's short interest increasing or decreasing? Albireo Pharma saw a decrease in short interest in the month of February. As of February 15th, there was short interest totaling 553,900 shares, a decrease of 19.8% from the previous total of 690,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Albireo Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Albireo Pharma: Centessa Pharmaceuticals plc (2.14%), MacroGenics, Inc. (14.65%), Tyra Biosciences, Inc. (13.78%), ABIVAX Société Anonyme (0.19%), Cassava Sciences, Inc. (29.69%), ALX Oncology Holdings Inc. (13.47%), Liquidia Co. (10.57%), OPKO Health, Inc. (23.81%), Homology Medicines, Inc. (0.81%), ARS Pharmaceuticals, Inc. (14.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.09 billion), Occidental Petroleum Co. ($3.00 billion), T. Rowe Price Group, Inc. ($2.35 billion), Coinbase Global, Inc. ($2.30 billion), Paramount Global ($2.04 billion), Etsy, Inc. ($1.90 billion), Voya Financial, Inc. ($1.77 billion), CarMax, Inc. ($1.67 billion), Royal Caribbean Cruises Ltd. ($1.58 billion), and Monolithic Power Systems, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short Albireo Pharma stock? Short selling ALBO is an investing strategy that aims to generate trading profit from Albireo Pharma as its price is falling. ALBO shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Albireo Pharma? A short squeeze for Albireo Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALBO, which in turn drives the price of the stock up even further. How often is Albireo Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALBO, twice per month. The most recent reporting period available is February, 15 2023. More Short Interest Resources from MarketBeat Related Companies: CNTA Short Squeeze MGNX Short Squeeze TYRA Short Squeeze ABVX Short Squeeze SAVA Short Squeeze ALXO Short Squeeze LQDA Short Squeeze OPK Short Squeeze FIXX Short Squeeze SPRY Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALBO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily